Schubert & CO Charles River Laboratories International, Inc. Transaction History

Schubert & CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$191.89 - $259.92 $767 - $1,039	-4 Reduced 36.36%	7 $1,000
Q4 2022 Jan 31, 2023	BUY	$197.11 - $250.07 $1,576 - $2,000	8 Added 266.67%	11 $2,000
Q3 2022 Oct 21, 2022	SELL	$182.44 - $250.54 $729 - $1,002	-4 Reduced 57.14%	3 $1,000
Q2 2022 Aug 01, 2022	BUY	$204.13 - $302.4 $408 - $604	2 Added 40.0%	7 $1,000
Q1 2022 May 16, 2022	SELL	$255.51 - $362.11 $1,022 - $1,448	-4 Reduced 44.44%	5 $1,000
Q4 2021 Jan 28, 2022	BUY	$351.38 - $448.68 $3,162 - $4,038	9 New	9 $3,000

696

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.56B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Schubert & CO, based on Form 13F filings with the SEC.

Stay updated on Schubert & CO with notifications on news.